Prellis Biologics

Prellis Biologics
https://www.prellisbio.com/

Field:
Tissue Engineering

Focus:
Body

Type: Startup
Founded: 2016
HQ: United States

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation.
[Learn +]
Leadership
Melanie Matheu
Founder
[LinkedIn]
[Twitter]

Noelle Mullin
Founder
[LinkedIn]
[Twitter]

Funding


Raised Capital
Year
Type
Offered / Sold Amount
Filings
Reported by Press*
Round
2019
8.7M USD
Series A
2017
1.87M USD
Seed
Known Investors
Name
Type
HQ
Other Relevant Investments
Cantos
Venture Capital
United States
Civilization Ventures
Venture Capital
United States
IndieBio
Accelerator
United States
Khosla Ventures
Venture Capital
United States
Kernel
Mojo Vision
Openwater
Editas Medicine
Synchron
Plug and Play
Accelerator
United States
McLEAR
suitX
SOSV
Venture Capital
United States
Nuada
Motiv
True Ventures
Venture Capital
United States
Neosensory
*More data available at: [CB Insights] [CrunchBase] [PitchBook]
Related
News
How long until bioprinted organs are available to those on transplant lists?
3D-printed organs within the next five years